Jane Street Group, LLC Arcturus Therapeutics Holdings Inc. Call Options Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$18.08 - $25.38 $305,552 - $428,922	16,900 New	16,900 $392,000
Q1 2022 May 17, 2022	BUY	$17.64 - $39.57 $238,140 - $534,195	13,500 Added 11.79%	128,000 $3.45 Million
Q4 2021 Feb 15, 2022	BUY	$34.2 - $47.56 $167,580 - $233,044	4,900 Added 4.47%	114,500 $4.24 Million
Q3 2021 Nov 16, 2021	BUY	$27.88 - $58.25 $2.45 Million - $5.11 Million	87,700 Added 400.46%	109,600 $5.24 Million
Q2 2021 Aug 16, 2021	SELL	$25.79 - $42.11 $2.52 Million - $4.12 Million	-97,800 Reduced 81.7%	21,900 $741,000
Q1 2021 May 18, 2021	SELL	$38.75 - $86.92 $2.36 Million - $5.3 Million	-61,000 Reduced 33.76%	119,700 $4.94 Million
Q4 2020 Feb 17, 2021	BUY	$34.61 - $123.66 $5.14 Million - $18.4 Million	148,500 Added 461.18%	180,700 $7.84 Million
Q3 2020 Nov 17, 2020	SELL	$37.49 - $63.19 $1.19 Million - $2 Million	-31,700 Reduced 49.61%	32,200 $1.38 Million
Q2 2020 Aug 17, 2020	BUY	$12.66 - $58.27 $808,974 - $3.72 Million	63,900 New	63,900 $2.99 Million

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $439M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.